Health Care

One challenge that policymakers face as they look to address the rise in the numbers of behavioral health patients waiting in hospital emergency departments for a bed to become available is that none of the underlying problems have easy solutions, Sen. Julian Cyr said Tuesday.

UMass Chan Medical School in Worcester announced its public service consulting division, Commonwealth Medicine has launched a new Center on Child Wellbeing and Trauma in partnership with the Massachusetts Office of the Child Advocate, according to a Thursday press release.

Pharmacy benefit manager platform provider nirvanaHealth announced Monday it will launch a Medicare Advantage program which will be available on Amazon Web Services.

The Edward M. Kennedy Community Health Center, headquartered in Worcester, announced Wednesday its Milford facility is moving across the street, tripling the center’s current square footage and increasing the resources it provides to town residents.

Hologic, a Marlborough medical technology company focused on women’s health, acquired Bolder Surgical, a Colorado-based company focused on energy vessel sealing surgical devices, in a $160-million dollar agreement announced on Thursday.

UMass Memorial Health announced Wednesday its plans to donate $1 million to the City of Worcester to establish of the Worcester Health Equity Fund.

A UMass Chan Medical School research team was awarded a four-year, $12.3-million grant from the National Institutes of Health to study and develop a treatment program for adults with opioid-use disorders.

In an internal memo, the UMass Memorial Health workforce was notified that caregivers who did not receive their COVID-19 vaccines would be terminated on Dec. 1.

Pillar Biosciences Inc. of Natick announced Thursday a partnership with North Carolina-based Labcorp to provide genomic testing for people with cancer.

CRISPR Therapeutics, a biotech firm specializing in gene-based medicines headquartered in Switzerland with a manufacturing plant in Framingham, announced Thursday updated trial results for its cell therapy.